Fidia Advances POC Financing with New Share Issue to GGHL

Fidia Spa ( (IT:FDA) ) has provided an announcement.

Fidia S.p.A. has converted three bonds from the fourth tranche of its 2026 convertible bond with warrants reserved for Global Growth Holding Limited, issuing 1,000,000 new shares at €0.03 each. The new shares are admitted directly to trading on the regulated market under the existing prospectus, further advancing the execution of the company’s planned capital increase.

Following these conversions, the POC has been subscribed for a nominal €1,000,000, with €810,000 of the related capital increase already subscribed and 19 bonds still outstanding and unconverted. Fidia’s share capital rises by €30,000 to €10,657,761.90, bringing the total number of shares to 43,542,927, a step that strengthens its equity base while modestly diluting existing shareholders as it continues its financing program with GGHL.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of numerical control technology and integrated high‑performance milling systems. The group focuses on advanced solutions for the automotive mould sector and the aerospace industry, offering numerical controls, high‑speed milling machines and CAM software that cover the entire milling process from programming to finished part.

YTD Price Performance: -73.33%

Average Trading Volume: 1,264,726

Technical Sentiment Signal: Strong Sell

Current Market Cap: €969.2K

For an in-depth examination of FDA stock, go to TipRanks’ Overview page.